cFluor® V547 Anti-Human CD71 (OKT9)
View Cart or Continue shopping.
Description
The OKT9 monoclonal antibody binds to human CD71, a 170-180 kDa type II transmembrane protein. CD71, the transferrin receptor, exists as a homodimer on the cell surface and is essential for cellular growth. CD71 is expressed by immature proliferating cells and at low levels on resting mature lymphocytes. Antigen or mitogen stimulation of T and B cells upregulates the expression of CD71. The transferrin receptor is also present on early erythroid cells, but is lost as reticulocytes differentiate into mature erythrocytes.
The antibody was conjugated to a fluorophore and purified by chromatography.
PRODUCT DETAILS
Clone: OKT9
Specificity: CD71
Reactivity: Human
Format: cFluor® V547*
Isotype: Mouse IgG1, κ
Tested Dilution: 5 µL / test
Application: Flow Cytometry
Storage: 2-8°C and protected from light. Do not freeze
Formulation: Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide and 0.2% BSA (BSA Country of Origin USA)
RECOMMENDED USAGE
Each lot of this antibody is quality control tested using flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µL per 1 million cells in a staining volume of 100 µL. If whole blood is analyzed, then use 5 µL per 100 µL. It is recommended that users titrate the antibody to obtain the optimal result for their specific application.
Please briefly centrifuge the reagent vial before use.
Use appropriate personal protective equipment per the product safety data sheet when using this product.
REFERENCES
1. Hentze MW, et al. 1996. Proc Natl Acad Sci U S A. 93:8175-82.
2. Trowbridge IS, et al. 1993. Annu Rev Cell Biol. 9:129-61.
For research use only. Not intended for use in diagnostic procedures.
*cFluor® V547 is equivalent to CF®405L manufactured and provided by Biotium, Inc. under an Agreement between Biotium and Cytek (LICENSEE). The manufacture, use, sale, offer for sale, or import of the product is covered by one or more of the patents or pending applications owned or licensed by Biotium. The purchase of this product includes a limited, non-transferable immunity from suit under the foregoing patent claims for using only this amount of product for the purchaser’s own internal research. No right under any other patent claim, no right to perform any patented method, and no right to perform commercial services of any kind, including without limitation reporting the results of purchaser's activities for a fee or other commercial consideration, is conveyed expressly, by implication, or by estoppel.